2025 beat expectations, but December softness hints at mounting household strain.

CEO Michael Fiddelke is moving swiftly to spark growth after 12 quarters of sluggish sales.

Early ChatGPT ads favor learning over ROI; high CPMs and limited measurement skew participation toward brands buying influence and insight.

Novo’s lawsuit and regulator warnings signal a crackdown on compounded GLP-1s across telehealth.

Aetna is finally finding its footing, managing medical costs more effectively, even as industry-wide pressures remain.

Its recent Pfizer and TrumpRx partnerships show how pharma companies are betting on D2C distribution and consumer-facing pricing.

Big linear TV won’t wow all viewers, but the massive reach can still drive research, provider talks, and care.

Paramount upped cash guarantees and fees in its WBD offer, betting richer terms can beat Netflix despite repeated board rejections.

Record subscriptions and better-than-expected revenues boosted shares 15%, but users—not ads—are still doing the heavy lifting

TikTok and Uber turned TV ads into app engagement, showing the game now drives measurable action, not just buzz.

Meta spent heavily on unskippable TV to sell teen safety, treating paid media as reputation risk management.

Racial representation in Super Bowl ads rose versus last year but lagged behind 2024, while celebrities skewed white and LGBTQ visibility fell again.

Over 30% of 2025 NFL views came in the offseason, proving digital sports content lives on far beyond game day.